Experts hailed exciting news for some people with sickle cell disease in England as the health watchdog decided to grant ...

Australian cancer researchers are the first to establish a next-generation gene-editing tool for modeling and interrogating ...

A £1.65 million treatment has been approved for use for some NHS patients, offering some with an inherited blood disorder ...

Australian cancer researchers are the first to establish a next-generation gene-editing tool for modeling and interrogating human disease.

In 2019, the first CRISPR clinical trials were conducted to treat sickle cell diseases and in 2020, this treatment was ...

It’s a new way to create “bi-paternal” mice that can survive to adulthood—but human applications are still a long way off.

Base editing utilizes enzymes to modify single amino acids at the most foundational unit of DNA, called a base.

RFK Jr.'s comments about the gene-editing technology raise a question about how he would regulate it as head of HHS.

Australian cancer researchers are the first to establish a next-generation gene-editing tool for modelling and interrogating human disease.

NanoCas, an ultracompact nuclease, enables efficient muscle editing in NHPs using a single AAV - advancing gene editing for hard-to-target tissues.

The gene therapy Casgevy, which will now be offered to some patients in England, could help people live disease-free, experts ...

It's the clearest view yet of RFK Jr.'s investments and potential conflicts of interest as he works to become HHS secretary.